Summit Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $613K | Sell |
8,777
-112
| -1% | -$7.83K | 0.01% | 528 |
|
|
2025
Q1 | $653K | Sell |
8,889
-753
| -8% | -$55.3K | 0.02% | 448 |
|
|
2024
Q4 | $632K | Sell |
9,642
-198
| -2% | -$13K | 0.02% | 407 |
|
|
2024
Q3 | $767K | Buy |
9,840
+4,224
| +75% | +$329K | 0.03% | 304 |
|
|
2024
Q2 | $438K | Buy |
+5,616
| New | +$438K | 0.02% | 351 |
|
|
2024
Q1 | – | Sell |
-3,078
| Closed | -$207K | – | 386 |
|
|
2023
Q4 | $207K | Buy |
+3,078
| New | +$207K | 0.01% | 338 |
|
|
2023
Q2 | – | Sell |
-7,195
| Closed | -$499K | – | 322 |
|
|
2023
Q1 | $499K | Buy |
7,195
+4,036
| +128% | +$280K | 0.04% | 171 |
|
|
2022
Q4 | $214K | Buy |
+3,159
| New | +$214K | 0.02% | 232 |
|